We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion)
How investigators and sponsors should manage clinical trials during COVID-19
The new COVID-19 vaccine from SK Chemicals, has been authorised after meeting the MHRA’s required safety, quality and effectiveness standards.
Guidance for living safely with respiratory infections, including coronavirus (COVID-19).
Projects granted during 2016 that have a primary purpose of basic research, immune system.
Information on the third and booster doses for people with a weakened immune system.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
The latest reproduction number (R) and growth rate of coronavirus (COVID-19).
Information about the Shingrix® vaccine for people with weakened immune systems.
National marketing campaign launches today, targeting those eligible but still unvaccinated.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.